Japanese Pharma CEOs Gearing Up for New Endeavors in 2020, Fret Scope of Off-Year Re-Pricing

January 9, 2020
Looking to deliver sustainable growth over the long haul, Japanese pharma leaders voiced their resolves at the industry’s New Year confab on January 8 to continue solidifying their business foundations by feeding resources into their respective fields of focus. Daiichi...read more